Diabetes Drug Table

Diabetes Drug Table - Pharmacologic Agents in the...

Info iconThis preview shows pages 1–2. Sign up to view the full content.

View Full Document Right Arrow Icon

Info iconThis preview has intentionally blurred sections. Sign up to view the full version.

View Full DocumentRight Arrow Icon
This is the end of the preview. Sign up to access the rest of the document.

Unformatted text preview: Pharmacologic Agents in the Management of Type I I Diabetes Mellitus, an Introduction D rug Class MOA Clinical Effect* Patient Education BIGUANIDES (Metformin) Decrease hepatic glucose output and sensitizes peripheral tissue to insulin A1C 1.5-2% FPG 50-70 mg/dL GI SEs (N/V/D, anorexia, metallic taste) take with food to minimize GI SEs Rare Lactic Acidosis risk SULFONYLUR EAS (Glipizide, Glimepiride, Glyburide) Insulin secretagogue (stimulate pancreatic insulin secretion) A1C 1-2 % FPG 50-70 mg/dL PPG 48 mg/dL Hypoglycemia risk Weight gain Sun sensitivity (sunscreen!) THIAZOLIDIN E-DIONES (Pioglitazon e) PPAR gamma agonist, decreases hepatic glucose output and sensitizes peripheral tissue to insulin A1C 0.5-1.4% FPG 40-55 mg/dL Weight gain Increased ovulation (females) Hepatotoxicity (jaundice) Osteoporosis risk (take calcium) Cardiac risk? (MI) NON- SULFONYLUR EA SECRETAGOG UES (Repaglinide , Nateglinide) Insulin secretagogue (stimulate pancreatic...
View Full Document

This note was uploaded on 09/14/2011 for the course PHARM TBL taught by Professor Staff during the Spring '11 term at UCSD.

Page1 / 2

Diabetes Drug Table - Pharmacologic Agents in the...

This preview shows document pages 1 - 2. Sign up to view the full document.

View Full Document Right Arrow Icon
Ask a homework question - tutors are online